Expression of FOXA1 in breast cancer and the significance
Journal Title: European Journal of Gynaecological Oncology - Year 2019, Vol 40, Issue 1
Abstract
Objective: The aim of this study to examine the expression of FOXA1, ER, and PR in breast cancer and investigate the association between FOXA1 expression and clinical parameters. Materials and Methods: One hundred one cases with primary breast cancer were collected and immunohistochemistry was employed to examine the expression of FOXA1, ER, and PR. The correlation of FOXA1 and ER, PR expression with menopausal status, tumor size, clinical stage, histological grade, recurrence, and clinical index relationship was further analyzed. Results: The positive expression of FOXA1 was 67.3%. The positive expression rate of ER in positive FOXA1 group was 66.2% (45/68). The positive expression rate of PR in positive FOXA group was 57.4% (39/68). There was no correlation between FOXA1 expression and menopausal status. Analysis of the relationship between FOXA1 and tumor diameter showed that the percentage of tumor diameter ≤ 2 cm, 2-5 cm, and > 5cm was 52.9%, 32.4%, and 14.7% in positive FOXA1 group. The correlation with clinical staging showed that the percentage of Stages I, II, and III was 33.8%, 41.2% and 25%, respectively, in positive FOXA1 group. Analysis of histological grade showed that the percentage of grades 1, 2, and 3 was 48.5%, 20.6%, and 23.5%, respectively, in positive FOXA1 group. The positive expression rate of P53 was 30.9%, the recurrence rate was 14.7%, and the positive expression of FOXA1 had better DFS.
Authors and Affiliations
Weili He, Hening Zhai, Ningxia Wang
Role of transvaginal ultrasound in finding endometrial cancer in postmenopausal women with or without bleeding
Purpose of Investigation: To determine the endometrial thickness (ET) threshold to predict high risk of endometrial cancer (EC) in symptomatic and asymptomatic postmenopausal patients. It is also assessed whether additio...
Survival rate and complications after different types of pelvic exenteration for gynecological cancer
Pelvic exenteration (PE) is an operative method for one-moment removal of pelvic organs, including reproductive tract, bladder, and rectosidgmoid. It is most commonly indicated in gynecologic oncology for treatment of lo...
Taraxacum officinale extract induces antitumorigenic effects in ovarian carcinoma cell lines
Purpose of Investigation: Patients suffering from ovarian cancer often use mistletoe preparations in combination with Taraxacum officinale (dandelion) extracts as supplementary therapy to conventional medicine. However,...
The role of erythropoietin and erythropoietin receptor expression in breast cancer
Erythropoietin (EPO) plays a number of important functions in the body. Contrary to original beliefs, its activity is not limited to exerting effects on cells along the erythropoietic pathway. Newly published results con...
Diffusion magnetic resonance in cervical carcinoma: the role of apparent diffusion coefficient in the evaluation of treatment response
Purpose: The aim of the study was to determinate the role of apparent diffusion coefficient (ADC) in order to find cut-off values in the evaluation of treatment response. Materials and Methods: A retrospective study was...